Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• 1. Introduction: An Overview of the anatomy and physiology of the lung2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer4. Polymeric nanoparticles based drug delivery for lung cancer5. Solid lipid nanoparticles based drug delivery for lung cancer6. Liposomes and niosomes based drug delivery for lung cancer7. Dendrimers based drug delivery for lung cancer8. Micelles based drug delivery for lung cancer9. Nanoemulsions based drug delivery for lung cancer10. Nanomedicine-based inhalation treatments for lung cancer11. Towards development of novel diagnostic nano-imaging platform for lung cancer12. Hydrogel based drug delivery for lung cancer13. Quantum dots based drug delivery for lung cancer

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• 1. Introduction: An Overview of the anatomy and physiology of the lung2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer4. Polymeric nanoparticles based drug delivery for lung cancer5. Solid lipid nanoparticles based drug delivery for lung cancer6. Liposomes and niosomes based drug delivery for lung cancer7. Dendrimers based drug delivery for lung cancer8. Micelles based drug delivery for lung cancer9. Nanoemulsions based drug delivery for lung cancer10. Nanomedicine-based inhalation treatments for lung cancer11. Towards development of novel diagnostic nano-imaging platform for lung cancer12. Hydrogel based drug delivery for lung cancer13. Quantum dots based drug delivery for lung cancer

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• 1. Introduction: An Overview of the anatomy and physiology of the lung2. Major Challenges in the Lung Cancer Therapy : Distant Metastasis and Drug Resistance3. Active Targeting Systems (Ligands) / Receptor overexpressed on lung cancer4. Polymeric nanoparticles based drug delivery for lung cancer5. Solid lipid nanoparticles based drug delivery for lung cancer6. Liposomes and niosomes based drug delivery for lung cancer7. Dendrimers based drug delivery for lung cancer8. Micelles based drug delivery for lung cancer9. Nanoemulsions based drug delivery for lung cancer10. Nanomedicine-based inhalation treatments for lung cancer11. Towards development of novel diagnostic nano-imaging platform for lung cancer12. Hydrogel based drug delivery for lung cancer13. Quantum dots based drug delivery for lung cancer